Clinical Trial Update: Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis [Phase 4]

View source ↗

Summary

This update describes a Phase 4 trial evaluating avacopan versus reduced-dose glucocorticoids in ANCA-associated vasculitis, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• Avacopan (avacopan)

Snippet

Sponsor: Chiba University | Conditions: ANCA Associated Vasculitis (AAV) | Phase 4 | Status: RECRUITING